AbbVie News: Third-Quarter 2020 Financial Results

AbbVie News: Third-Quarter 2020 Financial Results

NORTH CHICAGO, IL (STL.News) AbbVie (NYSE: ABBV) announced financial results for the third quarter ended September 30, 2020.

“We continue to be very well positioned for the long-term. Results from key growth products – including Skyrizi, Rinvoq and Ubrelvy – continue to track ahead of our expectations, our aesthetics portfolio is demonstrating a strong V-shaped recovery, our hematologic-oncology franchise is delivering double-digit growth and we’re advancing numerous attractive late-stage pipeline programs,” said Richard A. Gonzalez, chairman and chief executive officer, AbbVie.  “We are also executing effectively on Allergan integration initiatives with synergy and accretion targets tracking well.”

NOTE: this is NOT complete release.

View complete release:

About Marty Smith 10908 Articles
Marty Smith is the Editor in Chief and a founder of STL.News,, and St. Louis Restaurant Review. As Editor in Chief, Smith is responsible for the content posted on the network with the help of the publishing team, which is located around the globe. Additionally, Smith is responsible for building a network of aggregator sites to manage the content involving thousands of sources.